What is the plausibility that all drugs will be designed by computers by the end of the decade?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Expert opinion on drug discovery - 19(2024), 5 vom: 09. Apr., Seite 507-510 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Medina-Franco, José L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Artificial intelligence |
|---|
| Anmerkungen: |
Date Completed 24.04.2024 Date Revised 25.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/17460441.2024.2331734 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369909364 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369909364 | ||
| 003 | DE-627 | ||
| 005 | 20240425233214.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240319s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/17460441.2024.2331734 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM369909364 | ||
| 035 | |a (NLM)38501288 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Medina-Franco, José L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a What is the plausibility that all drugs will be designed by computers by the end of the decade? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.04.2024 | ||
| 500 | |a Date Revised 25.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Artificial intelligence | |
| 650 | 4 | |a automatization | |
| 650 | 4 | |a computationally driven drug discovery | |
| 650 | 4 | |a computer-aided drug design | |
| 650 | 4 | |a de novo | |
| 650 | 4 | |a drug discovery | |
| 650 | 4 | |a education | |
| 650 | 4 | |a in silico drug design | |
| 700 | 1 | |a López-López, Edgar |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on drug discovery |d 2006 |g 19(2024), 5 vom: 09. Apr., Seite 507-510 |w (DE-627)NLM190518170 |x 1746-045X |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2024 |g number:5 |g day:09 |g month:04 |g pages:507-510 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/17460441.2024.2331734 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2024 |e 5 |b 09 |c 04 |h 507-510 | ||